Frontiers in Neurology is a multidisciplinary journal that addresses all areas of neurology to better understand, treat, and prevent neurological disorders. It is indexed in PubMed Central (PMC), Scopus, and the DOAJ.

Led by Field Chief Editor Prof. Irene Litvan (University of California, San Diego, USA), Frontiers in Neurology welcomes submissions that explore the diagnosis, nature, causes, treatment, and public health aspects of neurological disorders.

The journal covers a wide spectrum of basic, translational, and clinical research that help improve patient care, including but not limited to:

artificial intelligence in neurology
applied neuroimaging
autonomic disorders
cognitive behavioural neurology
dementia and neurodegenerative diseases
diagnostic and forensic neuropathology
endovascular and interventional neurology
epilepsy
experimental therapeutics
headache and neurogenic pain
movement disorders
multiple sclerosis and neuroimmunology
neuro-oncology and neurosurgical oncology
neuro-ophthalmology
neuro-otology
neurocritical and neurohospitalist care
neuroepidemiology
neurogenetics
neuroinfectious diseases
neurological biomarkers
neuromuscular disorders and peripheral neuropathies
neurorehabilitation
neurotechnology
neurotrauma
pediatric neurology
sleep disorders
stroke

In particular, the journal welcomes submissions that support and advance the UN’s Sustainable Development Goals (SDGs), notably SDG 3: Good Health and Well-Being.

Manuscripts that focus solely on surgical techniques, clinical trials, or case reports are not suitable for publication in this journal. Studies that do not provide significant insight into the neurological basis of disease or disorder, or those that do not contribute to the understanding of the fundamental mechanisms of neurology, diagnosis and treatment of neurological disorders are not appropriate for this journal.

The journal no longer accepts papers concerning simple bibliometric studies. Authors are still welcome to submit Systematic Reviews using publicly available data, but these must adhere to the PRISMA guidelines and have a conclusion related to neurological research. Studies without this primary focus will be transferred to a more applicable journal.

Frontiers’ journals require that manuscripts primarily comprising computational studies of public data, such as NHANES or Mendelian Randomization studies, must include appropriate validation. Please refer to the Frontiers Standards for research methodology policy for more information. Manuscripts not adhering to these standards will not be considered.

Frontiers in Neurology is committed to advancing developments in the field of neurology by communicating scientific knowledge to researchers, academics, clinicians and the public worldwide, to enable the scientific breakthroughs of the future.

Impact

Frontiers in Neurology

Epilepsy